Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Soft Tissue Sarcoma (STS) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Spain

Medical Oncology Department, HU Fundación Jimenez Diaz, Madrid, Madrid

Key details

Phase

Safety & dosing

Sponsor

Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas

Collaborators

TenaRx, Inc.

Enrollment target

~25 participants

Started

January 2025

Primary completion

April 2027

Age range

16 Years – 70 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas — Stella